About Veriphi
Veriphi is a company based in Auckland (New Zealand) founded in 2015 by Gregory Joseph Shanahan. Veriphi has raised $736.71 thousand across 3 funding rounds from investors including Callaghan Innovation and Snowball Effect. Veriphi offers products and services including Veriphi Flushing Analyser. Veriphi operates in a competitive market with competitors including Shift Labs, Gasgon Medical, Monidor, Evelabs and Interlinked, among others.
- Headquarter Auckland, New Zealand
- Founders Gregory Joseph Shanahan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Veriphi Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$736.71 K (USD)
in 3 rounds
-
Latest Funding Round
$372 K (USD), Grant
Jan 01, 2017
-
Investors
Callaghan Innovation
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Veriphi
Veriphi offers a comprehensive portfolio of products and services, including Veriphi Flushing Analyser.
Uses lasers to verify identity and concentration of intravenous drugs.
People of Veriphi
Unlock access to complete
Funding Insights of Veriphi
Veriphi has successfully raised a total of $736.71K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $372 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Veriphi
Veriphi has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Callaghan Innovation and Snowball Effect.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government programs access and business development services are provided.
|
Locked | Locked | Locked | |
|
Equity crowdfunding is facilitated for New Zealand high-growth companies.
|
Locked | Locked | Locked |
Investor details for Veriphi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veriphi
Investment portfolio details for Veriphi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Veriphi
Detailed financials for Veriphi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Veriphi Comparisons
Peer comparison for Veriphi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Veriphi
Veriphi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shift Labs, Gasgon Medical, Monidor, Evelabs and Interlinked, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Infusion rate monitoring devices are developed for gravity flow applications.
|
|
| Locked | Locked | Locked |
Manufacturer of infusion system for hospitals
|
|
| Locked | Locked | Locked |
Remote patient monitoring devices and software are developed for healthcare.
|
|
| Locked | Locked | Locked |
Smart infusion monitors are developed for hospitals and home care.
|
|
| Locked | Locked | Locked |
Safety connectors for IV infusion therapy are provided by Interlinked.
|
|
| Locked | Locked | Locked |
AI-based platform for cardiopulmonary monitoring is developed for ICU patients.
|
Detailed competitors of Veriphi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Veriphi
Complete news archive for Veriphi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veriphi
Veriphi was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Veriphi is headquartered in Auckland, New Zealand.
Veriphi is a funded company, having raised a total of $736.71K across 3 funding rounds to date.
Veriphi was founded in 2015 in Auckland, New Zealand, within the health technology sector. Laser-based analyzers and IV consumables are produced to verify drug identity and concentration, reducing errors in hospital intravenous administration. Proof-of-concept trials were completed by October 2017, with commercial versions now under development for hospital trials involving 15 oncology drugs at Auckland Hospital Pharmacy.
Veriphi's top competitors include Shift Labs, Evelabs and VenoVision.
Veriphi offers Veriphi Flushing Analyser.
Veriphi has 2 investors. Key investors include Callaghan Innovation, and Snowball Effect.